To view the webinar replay of “PRECISE-AD Phase 1b Blinded Interim Data Analysis"  Click Here

Posters & Publications

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

PMN310 | Amyloid-Beta

PMN310 Poster AAIC 2026

View
PMN440 | A-Syn Vaccine

Vaccination with Conformational Epitopes Derived from Computational Modeling Elicits Active Antibody Response Selective for Toxic Alpha-Synuclein Species

View
PMN267 | TDP-43

Rational Design of a Vaccine Against TDP-43 Proteinopathies Using a Pathogenic Epitope of Misfolded TDP-43

View
PMN310 | Amyloid-Beta

Relationship between efficacy and preferential targeting of soluble Aβ aggregates

View
PMN310 | Amyloid-Beta

Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer’s disease

View
EpiSelect™ Platform

Protein misfolding-specific epitope identification for passive and active immunotherapy of neurodegenerative diseases

View
PMN310 | Amyloid-Beta

PRECISE-AD, A Phase 1b, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PMN310 in Patients with Early Alzheimer's Disease

View
PMN310 | Amyloid-Beta

Leveraging recent advances in biomarkers to optimize early phase drug development in Alzheimer’s Disease

View
EpiSelect™ Platform

Prediction of Misfolding-Specific Epitopes in SOD1 Using EpiSelect™ (platform formerly called Collective Coordinates)

View
PMN267 | TDP-43

Rational Generation of Monoclonal Antibodies and Intrabodies Selective for Pathogenic TDP-43

View
PMN311 | AD Vaccine

Alzheimer's Disease Vaccine Presentation

View
PMN311 | AD Vaccine

Narration of Alzheimer's Disease Vaccine Presentation

View